| 000 | 01526 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517184108.0 | ||
| 264 | 0 | _c20180621 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2314-7156 | ||
| 024 | 7 |
_a10.1155/2017/4302320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeng, Wen | |
| 245 | 0 | 0 |
_aDecitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation. _h[electronic resource] |
| 260 |
_bJournal of immunology research _c2017 |
||
| 300 |
_a4302320 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aAutophagy |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aCell Cycle Checkpoints |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aEpigenetic Repression |
| 650 | 0 | 4 |
_aForkhead Box Protein O3 _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 700 | 1 | _aDai, Hanjun | |
| 700 | 1 | _aYan, Ming | |
| 700 | 1 | _aCai, Xiaojun | |
| 700 | 1 | _aLuo, Hong | |
| 700 | 1 | _aKe, Min | |
| 700 | 1 | _aLiu, Zeming | |
| 773 | 0 |
_tJournal of immunology research _gvol. 2017 _gp. 4302320 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2017/4302320 _zAvailable from publisher's website |
| 999 |
_c27774759 _d27774759 |
||